Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Phase 2

Terminated

Conditions: Plexiform Neurofibromas
NF1
Neurofibromatosis

Interventions: Drug: Sutent®/Sunitinib

First Posted Date: 2011-07-26

Last Posted Date: 2018-03-14

Lead Sponsor: Indiana University

Target Recruit Count: 19

Registration Number: NCT01402817

Locations: 🇺🇸
Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States

Comparative Research of Alzheimer's Disease Drugs

Not Applicable

Terminated

Conditions: Alzheimer's Disease
Dementia

Interventions: Drug: Donepezil
Drug: Galantamine
Drug: Rivastigmine

First Posted Date: 2011-05-30

Last Posted Date: 2017-02-27

Lead Sponsor: Indiana University

Target Recruit Count: 200

Registration Number: NCT01362686

Locations: 🇺🇸
Touchpoint, Fishers, Indiana, United States
🇺🇸
Methodist Center for Geriatric Medicine, Indianapolis, Indiana, United States
🇺🇸
University Clinical Neurology, Indianapolis, Indiana, United States

and more 2 locations

Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Other: CHICA ADHD Module

First Posted Date: 2011-05-10

Last Posted Date: 2016-01-25

Lead Sponsor: Indiana University

Target Recruit Count: 84

Registration Number: NCT01351064

Locations: 🇺🇸
Children's Health Services Research, Indianapolis, Indiana, United States

The CHICA Developmental Screening Study

Not Applicable

Completed

Conditions: Developmental Delay

Interventions: Other: CHICA DevScreen Module

First Posted Date: 2011-05-10

Last Posted Date: 2017-06-26

Lead Sponsor: Indiana University

Target Recruit Count: 360

Registration Number: NCT01351077

Locations: 🇺🇸
Children's Health Services Research, Indianapolis, Indiana, United States

The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia

Phase 4

Completed

Conditions: Psychotic Disorder NOS
Schizoaffective Disorder
Schizophrenia
Schizophreniform

Interventions: Drug: N-Acetyl Cysteine
Other: sugar pill

First Posted Date: 2011-04-21

Last Posted Date: 2019-05-08

Lead Sponsor: Indiana University

Target Recruit Count: 60

Registration Number: NCT01339858

Locations: 🇺🇸
Indiana University Psychotic Disorders Clinic, Indianapolis, Indiana, United States
🇺🇸
Prevention and Recovery Center for Early Psychosis (PARC), Indianapolis, Indiana, United States

Using Computers to Assist in Parental Smoking Cessation in a Pediatric Setting

Not Applicable

Completed

Conditions: Cigarette Smoking

Interventions: Other: CHICA Smoking Cessation Module
Other: CHICA Placebo

First Posted Date: 2011-04-13

Last Posted Date: 2017-09-13

Lead Sponsor: Indiana University

Target Recruit Count: 362

Registration Number: NCT01334216

Locations: 🇺🇸
Children's Health Services Research, Indianapolis, Indiana, United States

Universal Screening for Tuberculosis and Anemia With the CHICA System

Not Applicable

Completed

Conditions: Iron Deficiency Anemia
Tuberculosis

Interventions: Other: CHICA Diagnosis Module
Other: CHICA Placebo

First Posted Date: 2011-03-25

Last Posted Date: 2016-12-02

Lead Sponsor: Indiana University

Target Recruit Count: 2239

Registration Number: NCT01322841

Locations: 🇺🇸
Children's Health Services Research, Indianapolis, Indiana, United States

A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies

Completed

Conditions: Cystic Fibrosis
Pseudomonas Aeruginosa

First Posted Date: 2011-03-21

Last Posted Date: 2015-11-06

Lead Sponsor: Indiana University

Target Recruit Count: 27

Registration Number: NCT01319253

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux

Not Applicable

Terminated

Conditions: Laryngopharyngeal Reflux

Interventions: Drug: Placebo
Drug: dexlansoprazole

First Posted Date: 2011-03-17

Last Posted Date: 2019-10-01

Lead Sponsor: Indiana University

Target Recruit Count: 11

Registration Number: NCT01317472

Locations: 🇺🇸
Clarian North Hospital -- IUMG Clinic, Indianapolis, Indiana, United States

Alzheimer's Disease Multiple Intervention Trial

Not Applicable

Completed

Conditions: Alzheimer's Disease

Interventions: Behavioral: Best practices primary care
Behavioral: Home based occupational therapy

First Posted Date: 2011-03-15

Last Posted Date: 2016-03-08

Lead Sponsor: Indiana University

Target Recruit Count: 180

Registration Number: NCT01314950

Locations: 🇺🇸
Wishard Health Services, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy